Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.

Also called NCT03218137

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03218137
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT03218137. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-02-13 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular Contractions
Condition
Premature Ventricular Contraction (PVC)
Intervention (Drug)
Adenosine
Lead sponsor
Weill Medical College of Cornell University (class: other)

Record details

Record id
cardio:ct-nct03218137
Content hash
65839041fbd4d26e363b270596a53181b3340c53f0a38485867fec95696367ac